| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
CONTROVERSY IN CLINICAL ENDOCRINOLOGY |
Center for Human Nutrition, Department of Clinical Nutrition, and Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390-9052
Address all correspondence and requests for reprints to: Scott M. Grundy, M.D., Ph.D., Center for Human Nutrition, Department of Clinical Nutrition, and Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Y3.206, Dallas, Texas 75390-9052. E-mail: Scott.Grundy{at}UTSouthwestern.edu.
Context: The metabolic syndrome (MetS) is a multiplex risk factor for cardiovascular disease. The syndrome develops through interplay of obesity and metabolic susceptibility.
Objective: This article addresses whether the MetS construct has clinical utility.
Position: The National Cholesterol Education Program and other organizations have proposed that the MetS can be recognized clinically by a clustering of simple clinical measures including waist circumferences, blood pressure, triglycerides, high-density lipoproteins, and glucose. People with this clustering have most or all of the components of the MetS. Identifying the MetS has several advantages. It discovers persons who are at increased risk for cardiovascular disease. A diagnosis focuses more clinical attention on the underlying causes, notably obesity and other lifestyle factors; it thereby reinforces the utility of lifestyle changes in clinical practice. A diagnosis further informs physicians on choice and intensity of drug therapy for elevated cholesterol, aspirin prophylaxis, and blood pressure and glucose control. The introduction of the MetS has led to a large number of epidemiological, metabolic, and genetic studies that have heightened our understanding of the condition’s prevalence and pathogenesis. It has been a stimulus to the development of new drugs or drug combinations that will modify multiple risk factors simultaneously.
Conclusions: This author holds that the MetS counts as a multiplex cardiovascular risk factor that is clinically useful and will lead to advances in diagnosis and treatment of an important cause of cardiovascular disease.
This article has been cited by other articles:
 |
|
 |
|
  M. Russell, M. Bredella, P. Tsai, N. Mendes, K. K. Miller, A. Klibanski, and M. Misra Relative Growth Hormone Deficiency and Cortisol Excess Are Associated with Increased Cardiovascular Risk Markers in Obese Adolescent Girls J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2864 - 2871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sampath, M. T. Flowers, X. Liu, C. M. Paton, R. Sullivan, K. Chu, M. Zhao, and J. M. Ntambi Skin-specific Deletion of Stearoyl-CoA Desaturase-1 Alters Skin Lipid Composition and Protects Mice from High Fat Diet-induced Obesity J. Biol. Chem., July 24, 2009; 284(30): 19961 - 19973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Huang A comprehensive definition for metabolic syndrome Dis. Model. Mech., May 1, 2009; 2(5-6): 231 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cartier, M. Cote, I. Lemieux, L. Perusse, A. Tremblay, C. Bouchard, and J.-P. Despres Sex differences in inflammatory markers: what is the contribution of visceral adiposity? Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1307 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. D. Johnson, J. J. M. Kroon, F. L. Greenway, C. Bouchard, D. Ryan, and P. T. Katzmarzyk Prevalence of Risk Factors for Metabolic Syndrome in Adolescents: National Health and Nutrition Examination Survey (NHANES), 2001-2006 Arch Pediatr Adolesc Med, April 1, 2009; 163(4): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I-M. Liu, T.-F. Tzeng, and S.-S. Liou A Chinese Herbal Decoction, Dang Gui Bu Xue Tang, Prepared from Radix Astragali and Radix Angelicae sinensis, Ameliorates Insulin Resistance Induced by A High-Fructose Diet in Rats Evid. Based Complement. Altern. Med., February 20, 2009; (2009) nep004v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Johnson, S. E. Perez-Pozo, Y. Y. Sautin, J. Manitius, L. G. Sanchez-Lozada, D. I. Feig, M. Shafiu, M. Segal, R. J. Glassock, M. Shimada, et al. Hypothesis: Could Excessive Fructose Intake and Uric Acid Cause Type 2 Diabetes? Endocr. Rev., February 1, 2009; 30(1): 96 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-D. Wang, W.-J. Lee, F.-Y. Shih, C.-H. Huang, Y.-C. Chang, W.-J. Chen, Y.-T. Lee, and M.-F. Chen Relations of Epicardial Adipose Tissue Measured by Multidetector Computed Tomography to Components of the Metabolic Syndrome Are Region-Specific and Independent of Anthropometric Indexes and Intraabdominal Visceral Fat J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 662 - 669. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Y. Chan, F. Andreotti, and R. C. Becker Hypercoagulable States in Cardiovascular Disease Circulation, November 25, 2008; 118(22): 2286 - 2297. [Full Text] [PDF]
|
|
|
|
|
|
H. Ashrafian, C. W. le Roux, A. Darzi, and T. Athanasiou Effects of Bariatric Surgery on Cardiovascular Function Circulation, November 11, 2008; 118(20): 2091 - 2102. [Full Text] [PDF]
|
|
|
|
|
|
F. D'Aiuto, W. Sabbah, G. Netuveli, N. Donos, A. D. Hingorani, J. Deanfield, and G. Tsakos Association of the Metabolic Syndrome with Severe Periodontitis in a Large U.S. Population-Based Survey J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3989 - 3994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chinali, G. de Simone, M. J. Roman, L. G. Best, E. T. Lee, M. Russell, B. V. Howard, and R. B. Devereux Cardiac Markers of Pre-Clinical Disease in Adolescents With the Metabolic Syndrome: The Strong Heart Study J. Am. Coll. Cardiol., September 9, 2008; 52(11): 932 - 938. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Glueck, Ping Wang, R. Hutchins, M. R. Petersen, and K. Golnik Ocular Vascular Thrombotic Events: Central Retinal Vein and Central Retinal Artery Occlusions Clinical and Applied Thrombosis/Hemostasis, July 1, 2008; 14(3): 286 - 294. [Abstract] [PDF]
|
|
|
|
 |
|
 J.-P. Despres, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose, J. Rodes-Cabau, O. F. Bertrand, and P. Poirier Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk Arterioscler Thromb Vasc Biol, June 1, 2008; 28(6): 1039 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. N. Bratz, G. M. Dick, J. D. Tune, J. M. Edwards, Z. P. Neeb, U. D. Dincer, and M. Sturek Impaired capsaicin-induced relaxation of coronary arteries in a porcine model of the metabolic syndrome Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2489 - H2496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Greenstone Clinician's Corner: The Metabolic Syndrome: A Lifestyle Medicine Foe Worthy of a Seek and Destroy Mission American Journal of Lifestyle Medicine, April 1, 2008; 2(2): 109 - 112. [Abstract] [PDF]
|
|
|
|
|
|
S. M. Grundy Metabolic Syndrome Pandemic Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 629 - 636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Grundy A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor Eur. Heart J. Suppl., March 1, 2008; 10(suppl_B): B16 - B23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Natal, M. A. Fortuno, P. Restituto, A. Bazan, I. Colina, J. Diez, and N. Varo Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E52 - E60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Kem, X. Yu, E. Patterson, S. Huang, S. Stavrakis, B. Szabo, L. Olansky, J. McCauley, and M. W. Cunningham Autoimmune Hypertensive Syndrome Hypertension, November 1, 2007; 50(5): 829 - 834. [Full Text] [PDF]
|
|
|
|
|
|
C. Ruggiero, A. Cherubini, S. S. Najjar, and L. Ferrucci Reply J. Am. Coll. Cardiol., October 30, 2007; 50(18): 1810 - 1811. [Full Text] [PDF]
|
|
|
|
|
|
J. Gomez-Ambrosi, V. Catalan, B. Ramirez, A. Rodriguez, I. Colina, C. Silva, F. Rotellar, C. Mugueta, M. J. Gil, J. A. Cienfuegos, et al. Plasma Osteopontin Levels and Expression in Adipose Tissue Are Increased in Obesity J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3719 - 3727. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Friedlander and J. Weinreb Authors' response J Am Dent Assoc, June 1, 2007; 138(6): 711 - 712. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
